UNIVERSITY OF CAMBRIDGE

The University of Cambridge is one of the world's oldest universities and leading academic centres, and a selfgoverned

community of scholars. Its reputation for outstanding academic achievement is known world-wide and

reflects the intellectual achievement of its students, as well as the world-class research carried out by the staff.

The Cancer Research UK Cambridge Institute (CRUK CI) focuses on tackling questions relating to cancer

diagnosis, treatment and prevention, supported by world-class scientific facilities. Our aim is to be a focus for the

practical application of high-quality research, forming a bridge between the University of Cambridge and

Addenbrooke's Hospital. The Institute's location on the Cambridge Biomedical Campus and its membership of

many collaborative initiatives are vital in helping us to achieve our goals.

The Cambridge Biomedical Campus is home to Addenbrooke's Hospital, the University of Cambridge teaching

hospital, and many of our collaborating institutes, including the MRC Laboratory for Molecular Biology, the

Hutchison/MRC Research Centre, the Strangeways Research Laboratories for Genetic Epidemiology and the

Cambridge Institute for Medical Research. In the wider Cambridge area we also have extensive links with the

Wellcome Trust Sanger Institute, and the European Bioinformatics Institute.

CRUK CI is a key member of the Cambridge Cancer Centre: a partnership between the University of Cambridge,

Cancer Research UK, Cambridge University Hospitals NHS Foundation Trust and Cambridge University Health

Partners. The aim of the centre is to bring together researchers in biology, medicine, maths, physics, chemistry and biology, as well as clinicians and pharmaceutical companies from across the Cambridge region, whose reserch has implications for the prevention, detection or treatment of cancer. A key focus of the centre is translating the work done in Cambridge laboratories into benefits for patients in the clinic. The Cambridge Cancer Centre is also a member of the Organisation of European Cancer Institutes (OECI). UCAM has 40 years of experience in the application of magnetic resonance techniques to biological systems

 

Role In Project

UCAM will conduct studies with hyperpolarised 13C-labelled cell substrates in animal models of disease and in

cancer patients.